J&J vaccine adds to COVID-19 armoury, includes South African variant
Published
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against...
Full ArticlePublished
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against...
Full Article[Daily Maverick] 'Brilliant news,' says J&J principal investigator of the South African arm Professor Glenda Gray who herself..
Novavax, a little-known company supported by the United States federal government's Operation Warp Speed, announced that its..